Elizaveta M. Andreeva

Elizaveta M. Andreeva

Auto-generated profile, based on publicly available information

Elizaveta M. Andreeva

Almazov National Medical Research Center

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2025 in Pulmonary Circulation
Verified
Journal Article
Open access
NGNatalia Sergeevna Goncharova
Natalia Sergeevna Goncharova
DRDaria Ryzhkova
Daria Ryzhkova
KLKirill Lapshin
Kirill Lapshin
ARAnton Ryzhkov
Anton Ryzhkov
AMAryana Malanova
Aryana Malanova
OMOlga Moiseeva
Olga Moiseeva
Right ventricular heart failure (RV HF) is the leading cause of death in pulmonary arterial hypertension (PAH). Relevance of the low‐risk status assessment using available diagnostic tools requires a reliable confirmation. The study aimed to evaluate right ventricular perfusion and glucose metabolism using positron emission tomography (PET)/computed tomography (CT) with [13N]‐ammonia and [18F]‐fluorodeoxyglucose ([18F]‐FDG) in 30 IPAH patients (33.8 ± 9.4 years) according to ESC/ERS 2022 risk status. The ratio of SUVmaxRV/LV metabolism and SUVmaxRV/LV perfusion showed significant positive correlation with pulmonary artery pressure, right heart dilatation, NT‐proBNP level and negative correlation with the RV ejection fraction. The SUVmaxRV/LV perfusion and SUVmaxRV/LV metabolism ratios differed significantly according to risk status. Low risk patients had a SUVmaxRV/LV metabolism comparable to the controls without PH. The SUVmaxRV/LV perfusion ratio was elevated in low‐risk IPAH patients compared with controls. Increased SUVmaxRV/LV perfusion may be an early marker of coronary flow adaptation to RV pressure overload in low‐risk IPAH patients and requires further evaluation. Further long‐term studies are needed to determine the clinical relevance and cut‐off values for the RV/LV PET/CT with [13N]‐ammonia and [18F]‐fluorodeoxyglucose ([18F]‐FDG) uptake in different IPAH risk groups.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
AVAleksandr D. Vakhrushev
Aleksandr D. Vakhrushev
HLHeber Ivan Condori Leandro
Heber Ivan Condori Leandro
NGNatalia Sergeevna Goncharova
Natalia Sergeevna Goncharova
LKLev E. Korobchenko
Lev E. Korobchenko
LMLubov B. Mitrofanova
Lubov B. Mitrofanova
EMEvgeny N Mikhaylov
Evgeny N Mikhaylov
Objective. We aimed to assess the effects of renal denervation (RDN) on systemic and pulmonary hemodynamics in a swine model of thromboxane A2‐ (TXA2‐) induced pulmonary arterial hypertension (PAH). Methods. The study protocol comprised two PAH inductions with a target mean pulmonary artery pressure (PAP) of 40 mmHg at baseline and following either the RDN or sham procedure. Ten Landrace pigs underwent the first PAH induction; then, nine animals were randomly allocated in 1 : 1 ratio to RDN or sham procedure; the second PAH induction was performed in eight animals (one animal died of pulmonary embolism during the first PAH induction, and one animal died after RDN). In the RDN group, ablation was performed in all available renal arteries, and balloon inflation within artery branches was performed in controls. An autopsy study of the renal arteries was performed. Results. At baseline, the target mean PAP was achieved in all animals with 25.0 [20.1; 25.2] mcg of TXA2. The second PAH induction required the same mean TXA2 dose and infusion time. There was no statistically significant difference in the mean PAP at second PAH induction between the groups (39.0 ± 5.3 vs. 39.75 ± 0.5 mmHg, P > 0.05). In the RDN group, the second PAH induction resulted in a numerical but insignificant trend toward a decrease in the mean systemic blood pressure and systemic vascular resistance, when compared with the baseline induction (74 ± 18.7 vs. 90.25 ± 28.1 mmHg and 1995.3 ± 494.3 vs. 2433.7 ± 1176.7 dyn∗sec∗cm−5, P > 0.05, respectively). No difference in hemodynamic parameters was noted in the sham group between the first and second PAH induction. Autopsy demonstrated artery damage in both groups, but RDN resulted in more severe lesions. Conclusions. According to our results, RDN does not result in significant acute pulmonary or systemic hemodynamic changes in the TXA2‐induced PAH model. The potential chronic effects of RDN on PAH require further research.

24 April 2021 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
NGNatalia Sergeevna Goncharova
Natalia Sergeevna Goncharova
EAE. M. Andreeva
E. M. Andreeva
AVA. D. Vakhrushev
A. D. Vakhrushev
HLHeber Ivan Condori Leandro
Heber Ivan Condori Leandro
LMLada Murashova
Lada Murashova
EMEvgeny N Mikhaylov
Evgeny N Mikhaylov

18 December 2021 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
NGNatalia Sergeevna Goncharova
Natalia Sergeevna Goncharova
HLHeber Ivan Condori Leandro
Heber Ivan Condori Leandro
AVAleksandr D. Vakhrushev
Aleksandr D. Vakhrushev
EKElena G. Koshevaya
Elena G. Koshevaya
YSYury A. Skorik
Yury A. Skorik
EMEvgeny N Mikhaylov
Evgeny N Mikhaylov
Background: Mechanisms of positive effects of pulmonary artery (PA) denervation (PADN) remain poorly understood. The study aimed to evaluate pulmonary hemodynamic changes after PADN and their association with the extent of PA wall damage in an acute thromboxane A2 (TXA2)-induced pulmonary hypertension (PH) model in swine. Methods: In this experimental sham-controlled study, 17 normotensive male white Landrace pigs (the mean weight 36.2 ± 4.5 kg) were included and randomly assigned to group I (n = 9)—PH modeling before and after PADN, group II (n = 4)—PADN only, or group III (n = 4)—PH modeling before and after a sham procedure. Radiofrequency (RF) PADN was performed in the PA trunk and at the proximal parts of the right and left PAs. PA wall lesions were characterized at the autopsy study using histological and the immunohistochemical examination. Results: In groups I and II, no statistically significant changes in the mean pulmonary arterial pressure nor systemic blood pressure were found after PADN (−0.8 ± 3.4 vs 4.3 ± 8.6 mmHg, P = 0.47; and 6.0 ± 15.9 vs -8.3 ± 7.5 mmHg, P = 0.1; correspondingly). There was a trend towards a lower diastolic pulmonary arterial pressure after PADN in group I when compared with group III during repeat PH induction (34.4 ± 2.9 vs 38.0 ± 0.8; P = 0.06). Despite the presence of severe PA wall damage at the RF application sites, S100 expression was preserved in the majority of PA specimens. The presence of high-grade PA lesions was associated with HR acceleration after PADN (ρ = 0.68, p = 0.03). No significant correlation was found between the grade of PA lesion severity and PA pressure after PADN with or without PH induction. Conclusions: Extended PADN does not affect PH induction using TXA2. Significant PA adventitia damage is associated with HR acceleration after PADN. Possible delayed effects of PADN on perivascular nerves and pulmonary hemodynamics require further research in chronic experiments.

1 March 2003 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
VKV. I. Kaledin
V. I. Kaledin
VNV. P. Nikolin
V. P. Nikolin
TBT. Yu. Baimak
T. Yu. Baimak
MGM. R. Galyamova
M. R. Galyamova
NPN. A. Popova
N. A. Popova
EAE. M. Andreeva
E. M. Andreeva

29 September 2022 in The Anatomical Record
Verified
Journal Article
Closed access
AVAleksandr D. Vakhrushev
Aleksandr D. Vakhrushev
HLHeber Ivan Condori Leandro
Heber Ivan Condori Leandro
NGNatalia Sergeevna Goncharova
Natalia Sergeevna Goncharova
LKLev E. Korobchenko
Lev E. Korobchenko
LMLubov Borisovna Mitrofanova
Lubov Borisovna Mitrofanova
EMEvgeny N Mikhaylov
Evgeny N Mikhaylov